Acylindrical glass vial (b) stopped with a rubber stopper and sealed with a metal cap moulded around vial neck and lip with a plastic cap that is attached to the metal cap such that when the plastic cap is pulled off, the seal on the metal cap is broken; vial is in a cardboard box (a) with a paper …
Acylindrical glass vial (b) stopped with a rubber stopper and sealed with a metal cap moulded around vial neck and lip with a plastic cap that is attached to the metal cap such that when the plastic cap is pulled off, the seal on the metal cap is broken; vial is in a cardboard box (a) with a paper leaflet (c)
Number Of Parts
3
Part Names
a - box - Size: Length 5.7 cm x Width 2.9 cm x Depth 2.9 cm
b - vial - Size: Length 4.4 cm x Diam. 2.2 cm
c - leaflet (unfolded) - Size: Length 17.6 cm x Width 10.1 cm
(a) Front: "5 ML. Bio. 1600 // FLUOGEN®-B // Standardized according to the U.S. Public // Health Service requirements for the 1973-74 season. // Stock 4-1600-1-70 // PARKE-DAVIS"; bottom: "Preservative: 0.01% thimerosal (mercury deriv.) // Polysorbate 80, USP, added during manufacture. // U.S. Licence No. 1. Canadian Licence No. 1. // Store at temperature between 2° and 8° C. // (36° and 46° F.). // FREEZING DESTROYS POTENCY // PARKE, DAVIS & Company // Detroit, Michigan 48232 U.S.A."; back: "5 ML. Bio. 1600 // INFLUENZA VIRUS VACCINE, MONVALENT // (IMMUNIZING ANTIGEN, ETHER EXTRACTED) // C Contains no less than 500 CCA units per human dose // (0.5 ml.) of a type B influenza virus strain representative of // B/Hong Kong /5/72. // PARKE-DAVIS"; top: "USUAL ADULT DOSE – One intramuscular injection of // 0.5 ml. See package insert. // [dose repeated in French] // Prepared from formalin-stabilized, zonally-centrifuged // antigens, ether-extracted from virus propagated in the // extraembryonic fluid of the chick embryo. // U.S. Patent No. 3,105,012"; right side: "5 ML. Bio. 1600 // FLUOGEN®-B // PARKE-DAVIS [printed] // Exp. Date and Lot // Feb. [stamped] 75 [handwritten] // 903619A [stamped] // 120 // 455817 [printed]"; (b) front: "5 ML. Bio. 1600 // INFLUENZA VIRUS VACCINE MONOVALENT // (IMMUNIZING ANTIGEN, ETHER EXTRACTED) // FLUOGEN®-B // Contains no less than 500 CCA units per human // dose (0.5 ml.) of a type B influenza virus strain // representative of B/Hong Kong/5/72. // Parke, Davis & Co/Detroit, Mi 48232 USA C [printed] // USUAL ADULT DOSE – One // intramuscular injection of 0.5 // ml. See package insert. // Standardized according to the // U.S. Public Health Service // requirements for the 1973-74 // season. // U.S. Lic. No. 1. // Canadian Lic. No. 1. // Exp. Date and Lot [printed] // Feb. 5, 1975 // 903619A [stamped]"; bottom: "W // 88 [embossed]"; top: "FLIP // OFF [embossed]"; (c) FLUOGEN®-B // INFLUENZA VIRUS VACCINE, MONOVALENT // IMMUNIZING ANTIGEN, ETHER EXTRACTED // PARKE-DAVIS // DESCRIPTION // [text follows] // 121 878100 C-PF // FLUOGEN-B // (INFLUENZA VIRUS VACCINE, MONOVALENT) // IMMUNIZING ANTIGEN, ETHER EXTRACTED // [text continues from Description] // INDICATIONS // [text follows] // 121 878100 2 C-PF // FLUOGEN-B // (INFLUENZA VIRUS VACCINE, MONOVALENT) // IMMUNIZING ANTIGEN, ETHER EXTRACTED // [text continues from Indications] // CONTRAINDICATIONS // [text follows] // PRECAUTIONS // [text follows] // 121 878100 2 C-PF // FLUOGEN-B // (INFLUENZA VIRUS VACCINE, MONOVALENT) // IMMUNIZING ANTIGEN, ETHER EXTRACTED // ADVERSE REACTIONS // [text follows] // DOSAGE AND ADMINISTRATION // [text follows] // PACKAGE INFORMATION // [text follows] // REFERENCES // [text follows] // 121 878100 // PARKE, DAVIS & Co // Detroit Mi 48232 USA // A // Issued June 1973 // C-PF // [French translation accompanies English, alongside text throughout]"
Permanent Location
Storage Room 0010
0010-A3-5 Row G
Condition Remarks
Box yellowed, dented; no apparent problems with vial or leaflet
Copy Type
Original
Research Facts
This is a vaccine against the influenza virus and is administered intramuscular with a hypodermic syringe.